{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:24:05Z","timestamp":1784550245078,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","award":["VIS 16-06"],"award-info":[{"award-number":["VIS 16-06"]}],"id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.clbc.2021.10.004","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T06:30:59Z","timestamp":1634020259000},"page":"e374-e386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3398-1074","authenticated-orcid":false,"given":"Hee Jung","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-1536","authenticated-orcid":false,"given":"Seo Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei Hyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ho","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-8530","authenticated-orcid":false,"given":"Il Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7831-7874","authenticated-orcid":false,"given":"Beom Seok","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Hee","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2021.10.004_bib0001","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMra031301","article-title":"Ductal carcinoma in situ of the breast","volume":"350","author":"Burstein","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2021.10.004_bib0002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2008.18.3103","article-title":"Ductal carcinoma in situ: state of the science and roadmap to advance the field","volume":"27","author":"Kuerer","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0003","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.breast.2012.11.002","article-title":"Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy","volume":"22","author":"Schulz","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2021.10.004_bib0004","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2021.10.004_bib0005","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1259\/bjr\/30974918","article-title":"Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy","volume":"85","author":"Suh","year":"2012","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0006","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/bjs.6162","article-title":"Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast","volume":"95","author":"Ansari","year":"2008","journal-title":"Br J Surg"},{"key":"10.1016\/j.clbc.2021.10.004_bib0007","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10549-010-1198-z","article-title":"Ductal carcinoma in situ: trends in treatment over time in the US","volume":"127","author":"Zujewski","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2021.10.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/480840","article-title":"A simple model to assess the probability of invasion in ductal carcinoma in situ of the breast diagnosed by needle biopsy","volume":"2014","author":"Coufal","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.clbc.2021.10.004_bib0009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/cncr.22435","article-title":"Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates","volume":"109","author":"Houssami","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2021.10.004_bib0011","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1148\/radiology.217.2.r00nv08466","article-title":"Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted?","volume":"217","author":"Lee","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2021.10.004_bib0012","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41416-018-0276-6","article-title":"A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers","volume":"119","author":"Meurs","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2021.10.004_bib0013","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","article-title":"Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ","volume":"200","author":"Yen","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.clbc.2021.10.004_bib0014","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.crad.2008.08.007","article-title":"Prediction of the presence of invasive disease from the measurement of extent of malignant microcalcification on mammography and ductal carcinoma in situ grade at core biopsy","volume":"64","author":"O'Flynn","year":"2009","journal-title":"Clin Radiol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0015","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1245\/s10434-010-1438-9","article-title":"Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy","volume":"18","author":"Houssami","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0016","doi-asserted-by":"crossref","first-page":"e805","DOI":"10.1016\/j.clbc.2018.04.011","article-title":"Development of a model to predict invasiveness in ductal carcinoma in situ diagnosed by percutaneous biopsy-original study and critical evaluation of the literature","volume":"18","author":"Doria","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2021.10.004_bib0017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.breast.2016.04.008","article-title":"Diagnostic performance of contrast-enhanced spectral mammography: systematic review and meta-analysis","volume":"28","author":"Tagliafico","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2021.10.004_bib0018","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.mric.2017.12.005","article-title":"Comparison of contrast-enhanced mammography and contrast-enhanced breast MR imaging","volume":"26","author":"Lewin","year":"2018","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"10.1016\/j.clbc.2021.10.004_bib0019","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s00330-015-3695-2","article-title":"Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria","volume":"25","author":"Lalji","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0020","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.crad.2016.05.009","article-title":"Contrast-enhanced spectral mammography improves diagnostic accuracy in the symptomatic setting","volume":"71","author":"Tennant","year":"2016","journal-title":"Clin Radiol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0021","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejrad.2017.10.001","article-title":"Comparison of screening CEDM and MRI for women at increased risk for breast cancer: a pilot study","volume":"97","author":"Jochelson","year":"2017","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0022","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiol.2019182660","article-title":"Performance of dual-energy contrast-enhanced digital mammography for screening women at increased risk of breast cancer","volume":"293","author":"Sung","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2021.10.004_bib0023","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1007\/s00330-016-4336-0","article-title":"Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study","volume":"26","author":"Lalji","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0024","first-page":"4359","article-title":"Comparison of the mammography, contrast-enhanced spectral mammography and ultrasonography in a group of 116 patients","volume":"36","author":"Luczynska","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clbc.2021.10.004_bib0025","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/0284185118822639","article-title":"Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications: diagnostic accuracy and impact on surgical management","volume":"60","author":"Houben","year":"2019","journal-title":"Acta Radiol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0026","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1148\/radiol.2017161592","article-title":"Newly diagnosed breast cancer: comparison of contrast-enhanced spectral mammography and breast MR Imaging in the evaluation of extent of disease","volume":"285","author":"Lee-Felker","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.clbc.2021.10.004_bib0027","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.crad.2017.10.017","article-title":"Factors affecting the precision of lesion sizing with contrast-enhanced spectral mammography","volume":"73","author":"Travieso-Aja","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0028","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00330-015-3904-z","article-title":"Clinical utility of dual-energy contrast-enhanced spectral mammography for breast microcalcifications without associated mass: a preliminary analysis","volume":"26","author":"Cheung","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162740","article-title":"Dual-energy contrast-enhanced spectral mammography: enhancement analysis on BI-RADS 4 non-mass microcalcifications in screened women","volume":"11","author":"Cheung","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2021.10.004_bib0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejrad.2018.07.021","article-title":"Quantification of enhancement in contrast-enhanced spectral mammography using a custom-made quantifier tool (I-STRIP): a proof-of-concept study","volume":"106","author":"Lobbes","year":"2018","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0031","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.breast.2013.03.009","article-title":"A nomogram for predicting underestimation of invasiveness in ductal carcinoma in situ diagnosed by preoperative needle biopsy","volume":"22","author":"Park","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2021.10.004_bib0032","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jso.24037","article-title":"A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast","volume":"112","author":"Kondo","year":"2015","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0033","doi-asserted-by":"crossref","first-page":"e77826","DOI":"10.1371\/journal.pone.0077826","article-title":"Development and evaluation of a prediction model for underestimated invasive breast cancer in women with ductal carcinoma in situ at stereotactic large core needle biopsy","volume":"8","author":"Diepstraten","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2021.10.004_bib0034","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1200\/JCO.18.00595","article-title":"Preoperative breast magnetic resonance imaging in women with local ductal carcinoma in situ to optimize surgical outcomes: results from the randomized phase III trial IRCIS","volume":"37","author":"Balleyguier","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2021.10.004_bib0035","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1200\/JCO.2015.66.2064","article-title":"Toward minimizing overtreatment and undertreatment of ductal carcinoma in situ in the United States","volume":"34","author":"Smith","year":"2016","journal-title":"J Clin Oncol"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921002950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820921002950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:23:26Z","timestamp":1761513806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820921002950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1526820921002950"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2021.10.004","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2021.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}